Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records
Open Access
- 11 June 2021
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-9
Abstract
Serosurveillance provides a unique opportunity to quantify the proportion of the population that has been exposed to pathogens. Here, we developed and piloted Serosurveillance for Continuous, ActionabLe Epidemiologic Intelligence of Transmission (SCALE-IT), a platform through which we systematically tested remnant samples from routine blood draws in two major hospital networks in San Francisco for SARS-CoV-2 antibodies during the early months of the pandemic. Importantly, SCALE-IT allows for algorithmic sample selection and rich data on covariates by leveraging electronic health record data. We estimated overall seroprevalence at 4.2%, corresponding to a case ascertainment rate of only 4.9%, and identified important heterogeneities by neighborhood, homelessness status, and race/ethnicity. Neighborhood seroprevalence estimates from SCALE-IT were comparable to local community-based surveys, while providing results encompassing the entire city that have been previously unavailable. Leveraging this hybrid serosurveillance approach has strong potential for application beyond this local context and for diseases other than SARS-CoV-2.Keywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (MIDASNI2020- 5, 3U24GM132013-02S2)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
This publication has 28 references indexed in Scilit:
- Opportunities and challenges of a World Serum Bank – Authors' replyThe Lancet, 2017
- Use of serological surveys to generate key insights into the changing global landscape of infectious diseaseThe Lancet, 2016
- Seroprevalence of Influenza A(H1N1)pdm09 Virus Antibody, England, 2010 and 2011Emerging Infectious Diseases, 2012
- Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 PandemicPLOS ONE, 2012
- Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia — a seroprevalence studyMedical Journal of Australia, 2011
- Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) PandemicPLOS ONE, 2010
- Sero‐immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong KongJournal of Medical Virology, 2010
- Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere WinterPLOS ONE, 2010
- High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009Eurosurveillance, 2010
- Conditional dependence between tests affects the diagnosis and surveillance of animal diseasesPreventive Veterinary Medicine, 2000